Divi's Laboratories Ltd. vs Torrent Pharmaceuticals Ltd.
A side-by-side comparison of DIVISLAB and TORNTPHARM on the metrics that matter — size, valuation, profitability, leverage and ownership. Figures reflect the latest data refresh; always confirm against company filings.
| Metric | DIVISLAB | TORNTPHARM |
|---|---|---|
| Share price | ₹6,681 | ₹4,778 |
| Market cap | ₹1.77L Cr | ₹1.62L Cr |
| P/E ratio | 69.24x | 74.78x |
| P/B ratio | 10.57x | 19.28x |
| ROE | 16.19% | 16.99% |
| EPS (TTM) | ₹96.48 | ₹63.90 |
| Dividend yield | 0.45% | 0.80% |
| Debt / equity | 0.00x | 0.85x |
| Revenue | ₹10560 Cr | ₹13980 Cr |
| Net profit | ₹2568 Cr | ₹2163 Cr |
| Promoter holding | 51.88% | 68.31% |
Common questions
Which is bigger, Divi's Laboratories Ltd. or Torrent Pharmaceuticals Ltd.?+
Divi's Laboratories Ltd. is the larger company by market capitalisation — about ₹1.77L Cr versus ₹1.62L Cr for Torrent Pharmaceuticals Ltd..
Which is cheaper by P/E, DIVISLAB or TORNTPHARM?+
Divi's Laboratories Ltd. trades on the lower price-to-earnings ratio (69.24x vs 74.78x), though a lower P/E can reflect slower expected growth.
Which pays a higher dividend, Divi's Laboratories Ltd. or Torrent Pharmaceuticals Ltd.?+
Torrent Pharmaceuticals Ltd. currently shows the higher trailing dividend yield (0.80%).